Mutational biosynthesis of butirosin analogs. I. Conversion of neamine analogs into butirosin analogs by mutants of Bacillus circulans.

Authors:
  • KTKatsuo Takeda
    Katsuo Takeda
  • SOSatoshi Okuno
    Satoshi Okuno
  • YOYoshitami Ohashi
    Yoshitami Ohashi
  • TFTamotsu Furumai
    Tamotsu Furumai

Abstract
By N-methyl-N''-nitro-N-nitrosoguanidine treatment, neamine-negative mutants which required neamine for biosynthesis of butirosins were obtained from a butirosin-producing organism, B. circulans. These mutants also produced butirosins from paromamine and could be divided into 2 types I and II. Mutants of type I could not produce butirosins from 2-deoxystreptamine, whereas those of type II could. Two typical mutants MCRL 5003 (type I) and MCRL 5004 (type II) could produce butirosin analogs, 3'',4''-dideoxybutirosins, 6''-N-methylbutirosins, 3'',4''-dideoxy-6''-N-methylbutirosins and 3'',4''-dideoxy-6''-C-methylbutirosins from neamine analogs, gentamine C1.alpha., 6''-N-methylneamine, 6''-N-methylgentamine C1.alpha. and gentamine C2, respectively.